13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurotechnology Developers
Neurotechnology developers work at the intersection of neuroscience and engineering, creating innovative tools that enhance our understanding of the brain and improve treatments for neurological conditions. They design and implement technologies such as brain-computer interfaces (BCIs), neural prosthetics, and neuroimaging devices to monitor, diagnose, and treat neurological disorders. These specialists collaborate with neuroscientists, clinicians, and biomedical engineers to develop devices that can interface directly with the brain, providing patients with the ability to control prosthetic limbs or communicate through thought. Neurotechnology developers are also involved in the creation of advanced neuroimaging systems, which allow for detailed, real-time observation of brain activity in patients with conditions like epilepsy or Parkinson’s disease. Their work extends to innovations in neural stimulation therapies, such as transcranial magnetic stimulation (TMS), which is used to treat mood disorders, pain, and neurological rehabilitation. With rapid advancements in artificial intelligence and machine learning, neurotechnology developers are increasingly leveraging these technologies to improve diagnostics, optimize treatment protocols, and provide personalized care. They play a pivotal role in advancing the field of neuroengineering, with the goal of improving the quality of life for individuals with neurological disorders through cutting-edge technologies.
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : Nanoparticles passing the blood brain barrier to treat cancer, infection, and more
Thomas J Webster, Brown University, United States
Title : Transcranial painless neurorehabilitation scalp acupuncture electrical stimulation for neuroregulation of autism spectrum disorder
Zhenhuan Liu, Guangzhou University Chinese Medicine, China
Title : Effects of prenatal androgen exposure on Purkinje cell morphology in the cerebellum of female rats
Kiran Ghotra, Lake Erie College of Osteopathic Medicine, United States